Extending the clinical heterogeneity of iodide transport defect (ITD): A novel mutation R124H of the sodium/iodide symporter gene and review of genotype-phenotype correlations in ITD

被引:37
作者
Szinnai, G
Kosugi, S
Derrien, C
Lucidarme, N
David, V'R
Czernichow, P
Polak, M
机构
[1] Hop Necker Enfants Malad, INSERM, Equipe Mixte 0363, Serv Endocrinol Pediat, F-75743 Paris 15, France
[2] Hop Necker Enfants Malad, Pediat Endocrine Unit, F-75743 Paris 15, France
[3] Kyoto Univ, Grad Sch Med, Dept Clin Genet, Kyoto 6068501, Japan
[4] Kyoto Univ, Grad Sch Med, Dept Med Eth, Kyoto 6068501, Japan
[5] Ctr Hosp Univ, Dept Endocrinol & Diabet, Mol Lab, F-35043 Rennes, France
[6] Hop Robert Debre, Pediat Endocrine & Diabet Unit, F-75019 Paris, France
关键词
D O I
10.1210/jc.2005-1832
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Iodide transport defect (ITD) is an autosomal recessive disorder resulting in varying degrees of congenital hypothyroidism (CH) with goiter and low or absent radioiodide uptake (RIUT), as determined by thyroid scintigraphy, and low iodide saliva to plasma ratio. Defects of the sodium/iodide symporter gene (NIS) have been shown to cause ITD. Objective: We describe molecular studies of NIS in a patient with ITD and genotype-phenotype correlation analysis in 31 patients with NIS defects reported worldwide. Design: NIS sequencing and functional studies of the new NIS mutation in vitro were performed. Results: In a newborn with symptomatic CH and a large goiter, thyroid scintigraphy showed no RIUT (0%). NIS sequencing identified the new homozygous mutation, R124H, in exon 2. This mutation was associated with abolition of iodide uptake in vitro when transfected in COS-7 cells. Immunocytochemical studies documented correct targeting of the mutated protein to the plasma membrane of transfected cells. Genotype-phenotype correlation analysis showed that the onset of hypothyroidism occurred during the neonatal period with four NIS mutations (neonatal onset of hypothyroidism genotype), during infancy with three NIS mutations (infancy onset of hypothyroidism genotype), and during childhood with three NIS mutations (childhood onset of hypothyroidism genotype). RIUT is a direct measure of residual NIS activity in vivo. Mean RIUT was lower in patients with the neonatal onset of hypothyroidism genotype (0.88 +/- 0.2%) than in the infancy onset of hypothyroidism (1.9 +/- 0.4%; P < 0.05) and childhood onset of hypothyroidism (2.6 +/- 0.7%; P < 0.05) genotypes. Conclusions: We identified a new NIS mutation, R124H, in a newborn with the complete clinical ITD phenotype. Genotype-phenotype correlations suggest that age at hypothyroidism onset may be genotype specific and may depend on genotype-specific residual NIS activity.
引用
收藏
页码:1199 / 1204
页数:6
相关论文
共 26 条
[1]  
ANDERSEN H J, 1961, Acta Paediatr Suppl, V50(Suppl 125), P1
[2]   Compound heterozygous mutations in the thyroglobulin gene (1143delC and 6725G3→A [R2223H]) resulting in fetal goitrous hypothyroidism [J].
Caron, P ;
Moya, CM ;
Malet, D ;
Gutnisky, VJ ;
Chabardes, B ;
Rivolta, CM ;
Targovnik, HM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (08) :3546-3553
[3]   Cloning and characterization of the thyroid iodide transporter [J].
Dai, G ;
Levy, O ;
Carrasco, N .
NATURE, 1996, 379 (6564) :458-460
[4]  
de Benoist Bruno., 2004, IODINE STATUS WORLDW
[5]   Molecular analysis of a congenital iodide transport defect:: G543E impairs maturation and trafficking of the Na+/I- symporter [J].
De la Vieja, A ;
Ginter, CS ;
Carrasco, N .
MOLECULAR ENDOCRINOLOGY, 2005, 19 (11) :2847-2858
[6]   The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number [J].
De la Vleja, A ;
Ginter, CS ;
Carrasco, N .
JOURNAL OF CELL SCIENCE, 2004, 117 (05) :677-687
[7]   The sodium/iodide symporter (NIS):: Characterization, regulation, and medical significance [J].
Dohán, O ;
De la Vieja, A ;
Paroder, V ;
Riedel, C ;
Artani, M ;
Reed, M ;
Ginter, CS ;
Carrasco, N .
ENDOCRINE REVIEWS, 2003, 24 (01) :48-77
[8]   Na+/I- symporter activity requires a small and uncharged amino acid residue at position 395 [J].
Dohán, O ;
Gavrielides, MV ;
Ginter, C ;
Amzel, LM ;
Carrasco, N .
MOLECULAR ENDOCRINOLOGY, 2002, 16 (08) :1893-1902
[9]   A novel V59E missense mutation in the sodium iodide symporter gene in a family with iodide transport defect [J].
Fujiwara, H ;
Tatsumi, K ;
Tanaka, S ;
Kimura, M ;
Nose, O ;
Amino, N .
THYROID, 2000, 10 (06) :471-474
[10]   Recurrent T354P mutation of the Na+/I- symporter in patients with iodide transport defects [J].
Fujiwara, H ;
Tatsumi, K ;
Miki, K ;
Harada, T ;
Okada, S ;
Nose, O ;
Kodama, S ;
Amino, N .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (08) :2940-2943